vs
Side-by-side financial comparison of Affinity Bancshares, Inc. (AFBI) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
Affinity Bancshares, Inc. is the larger business by last-quarter revenue ($8.6M vs $4.9M, roughly 1.7× Sensus Healthcare, Inc.). Affinity Bancshares, Inc. runs the higher net margin — 24.9% vs -64.1%, a 89.0% gap on every dollar of revenue. On growth, Affinity Bancshares, Inc. posted the faster year-over-year revenue change (12.8% vs -62.2%). Affinity Bancshares, Inc. produced more free cash flow last quarter ($11.2M vs $-2.4M). Over the past eight quarters, Affinity Bancshares, Inc.'s revenue compounded faster (8.1% CAGR vs -31.9%).
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
AFBI vs SRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.6M | $4.9M |
| Net Profit | $2.1M | $-3.2M |
| Gross Margin | — | 38.4% |
| Operating Margin | 35.9% | -63.8% |
| Net Margin | 24.9% | -64.1% |
| Revenue YoY | 12.8% | -62.2% |
| Net Profit YoY | 58.5% | -304.9% |
| EPS (diluted) | $0.34 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.6M | $4.9M | ||
| Q3 25 | $8.4M | $6.9M | ||
| Q2 25 | $8.3M | $7.3M | ||
| Q1 25 | $7.8M | $8.3M | ||
| Q4 24 | $7.6M | $13.1M | ||
| Q3 24 | $8.0M | $8.8M | ||
| Q2 24 | $8.3M | $9.2M | ||
| Q1 24 | $7.3M | $10.7M |
| Q4 25 | $2.1M | $-3.2M | ||
| Q3 25 | $2.2M | $-943.0K | ||
| Q2 25 | $2.2M | $-1.0M | ||
| Q1 25 | $1.8M | $-2.6M | ||
| Q4 24 | $1.3M | $1.5M | ||
| Q3 24 | $1.7M | $1.2M | ||
| Q2 24 | $1.0M | $1.6M | ||
| Q1 24 | $1.3M | $2.3M |
| Q4 25 | — | 38.4% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 52.2% | ||
| Q4 24 | — | 54.4% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 58.7% | ||
| Q1 24 | — | 62.5% |
| Q4 25 | 35.9% | -63.8% | ||
| Q3 25 | 34.9% | -37.3% | ||
| Q2 25 | 34.1% | -26.6% | ||
| Q1 25 | 30.8% | -31.7% | ||
| Q4 24 | 21.1% | 13.2% | ||
| Q3 24 | 28.5% | 16.9% | ||
| Q2 24 | 16.2% | 21.5% | ||
| Q1 24 | 24.0% | 27.1% |
| Q4 25 | 24.9% | -64.1% | ||
| Q3 25 | 26.5% | -13.7% | ||
| Q2 25 | 25.9% | -14.2% | ||
| Q1 25 | 23.4% | -30.8% | ||
| Q4 24 | 17.7% | 11.8% | ||
| Q3 24 | 21.7% | 13.7% | ||
| Q2 24 | 12.5% | 17.4% | ||
| Q1 24 | 18.2% | 21.3% |
| Q4 25 | $0.34 | $-0.19 | ||
| Q3 25 | $0.34 | $-0.06 | ||
| Q2 25 | $0.33 | $-0.06 | ||
| Q1 25 | $0.28 | $-0.16 | ||
| Q4 24 | $0.21 | $0.10 | ||
| Q3 24 | $0.26 | $0.07 | ||
| Q2 24 | $0.16 | $0.10 | ||
| Q1 24 | $0.20 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $53.9M | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $127.0M | $48.1M |
| Total Assets | $881.7M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.9M | $22.1M | ||
| Q3 25 | $84.8M | $24.5M | ||
| Q2 25 | $89.7M | $22.2M | ||
| Q1 25 | $74.7M | $19.1M | ||
| Q4 24 | $41.4M | $22.1M | ||
| Q3 24 | $52.3M | $22.6M | ||
| Q2 24 | $50.4M | $19.0M | ||
| Q1 24 | $61.4M | $14.7M |
| Q4 25 | $127.0M | $48.1M | ||
| Q3 25 | $125.4M | $51.2M | ||
| Q2 25 | $124.1M | $52.1M | ||
| Q1 25 | $122.3M | $53.0M | ||
| Q4 24 | $129.1M | $55.8M | ||
| Q3 24 | $128.4M | $54.1M | ||
| Q2 24 | $125.1M | $52.9M | ||
| Q1 24 | $123.3M | $51.2M |
| Q4 25 | $881.7M | $53.0M | ||
| Q3 25 | $925.2M | $58.3M | ||
| Q2 25 | $933.8M | $58.9M | ||
| Q1 25 | $912.5M | $60.2M | ||
| Q4 24 | $866.8M | $62.2M | ||
| Q3 24 | $878.6M | $59.9M | ||
| Q2 24 | $873.6M | $58.2M | ||
| Q1 24 | $869.5M | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.6M | $-2.2M |
| Free Cash FlowOCF − Capex | $11.2M | $-2.4M |
| FCF MarginFCF / Revenue | 130.9% | -47.9% |
| Capex IntensityCapex / Revenue | 4.9% | 3.2% |
| Cash ConversionOCF / Net Profit | 5.46× | — |
| TTM Free Cash FlowTrailing 4 quarters | $20.3M | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | $-2.2M | ||
| Q3 25 | $3.7M | $2.3M | ||
| Q2 25 | $3.8M | $3.1M | ||
| Q1 25 | $1.9M | $-2.7M | ||
| Q4 24 | $6.8M | $-827.0K | ||
| Q3 24 | $4.1M | $4.0M | ||
| Q2 24 | $619.0K | $4.2M | ||
| Q1 24 | $1.2M | $-8.2M |
| Q4 25 | $11.2M | $-2.4M | ||
| Q3 25 | $3.6M | $2.3M | ||
| Q2 25 | $3.7M | $3.1M | ||
| Q1 25 | $1.8M | $-2.7M | ||
| Q4 24 | $6.4M | $-1.1M | ||
| Q3 24 | $4.0M | $3.6M | ||
| Q2 24 | $489.0K | $4.2M | ||
| Q1 24 | $1.1M | $-8.4M |
| Q4 25 | 130.9% | -47.9% | ||
| Q3 25 | 43.3% | 33.3% | ||
| Q2 25 | 44.0% | 42.2% | ||
| Q1 25 | 22.7% | -32.2% | ||
| Q4 24 | 83.9% | -8.6% | ||
| Q3 24 | 49.5% | 40.9% | ||
| Q2 24 | 5.9% | 45.8% | ||
| Q1 24 | 14.8% | -79.0% |
| Q4 25 | 4.9% | 3.2% | ||
| Q3 25 | 0.8% | 0.1% | ||
| Q2 25 | 1.4% | 0.4% | ||
| Q1 25 | 1.9% | 0.1% | ||
| Q4 24 | 5.6% | 2.3% | ||
| Q3 24 | 1.7% | 3.8% | ||
| Q2 24 | 1.6% | 0.0% | ||
| Q1 24 | 1.8% | 2.2% |
| Q4 25 | 5.46× | — | ||
| Q3 25 | 1.66× | — | ||
| Q2 25 | 1.75× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 5.05× | -0.53× | ||
| Q3 24 | 2.36× | 3.25× | ||
| Q2 24 | 0.60× | 2.62× | ||
| Q1 24 | 0.91× | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AFBI
Segment breakdown not available.
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
